Century Therapeutics, Inc. SEC filings IPSC
Century Therapeutics, Inc. has 444 filings in SEC EDGAR's recent list, going back to Mar 15, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| EFFECT | Filing | Jan 9, 2026 | — |
| CORRESP | Letter to the SEC | Jan 7, 2026 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| EFFECT | Filing | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2024 | — |
| EFFECT | Filing | May 21, 2024 | — |
| CORRESP | Letter to the SEC | May 17, 2024 | — |
| UPLOAD | Letter from the SEC | May 17, 2024 | — |
| EFFECT | Filing | Jul 13, 2022 | — |
| CORRESP | Letter to the SEC | Jul 11, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2022 | — |
| EFFECT | Filing | Jun 17, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 17, 2021 | — |
| CERT | Withdrawing incorrect 8a cert, accession number: 0001354457-21-000666 | Jun 17, 2021 | — |
| CERT | Filing | Jun 16, 2021 | — |
| CERT | Filing | Jun 16, 2021 | — |
| CORRESP | Letter to the SEC | Jun 15, 2021 | — |
| CORRESP | Letter to the SEC | Jun 15, 2021 | — |
| 8-A12B | Filing | Jun 14, 2021 | — |
| CORRESP | Letter to the SEC | Jun 10, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 7, 2021 | — |
| CORRESP | Letter to the SEC | May 28, 2021 | — |
| UPLOAD | Letter from the SEC | May 21, 2021 | — |
| SEC STAFF LETTER | Filing | May 18, 2021 | — |
| DRSLTR | Filing | May 5, 2021 | — |
| DRS/A | Filing | May 5, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2021 | — |
| DRS | Filing | Mar 26, 2021 | — |
| D | Filing | Mar 15, 2021 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IPSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850119
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.